Share

Clinical Studies (1)

  • STIMULATE-ICP : Study aims to evaluate the effectiveness of an integrated care pathway in improving fatigue and physical, psychological, and functional outcomes in adults with Long COVID, and to assess, through an embedded Phase III open-label platform randomised drug trial, the efficacy of candidate therapies such as rivaroxaban, colchicine, and famotidine/loratadine compared with no drug treatment

Study Data

  • Adults (18-64 years)
  • General population
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Colchicine
  • Antihistamines
  • Rivaroxaban

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to